Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib may help treat severe hair loss, but more research is needed.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

5% minoxidil foam once daily works as well as 2% minoxidil solution twice daily for female hair growth and is more convenient.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Topical latanoprost and bimatoprost eye solutions don't help eyelash growth in people with alopecia areata.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Dupilumab for eczema may cause hair loss.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Nanoparticles improve minoxidil skin permeation, but more research needed for effective hair growth.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Tinea capitis can be misdiagnosed as bacterial infection in adult women but is treatable with antifungal medication.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.